2008
DOI: 10.1093/carcin/bgn070
|View full text |Cite
|
Sign up to set email alerts
|

Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling

Abstract: Most cancers are dependent on the growth of tumor blood vessels and inhibition of tumor angiogenesis may thus provide an efficient strategy to retard or block tumor growth. Recently, tumor vascular targeting has expanded to include not only endothelial cells (ECs) but also smooth muscle cells (SMCs), which contribute to a mature and functional vasculature. We have reported previously that delphinidin, a major biologically active constituent of berries, inhibits the vascular endothelial growth factor-induced ph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
37
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 54 publications
(39 citation statements)
references
References 59 publications
2
37
0
Order By: Relevance
“…Baicalin belongs to a class of polyphenols. Previous studies have shown that polyphenols inhibit PDGFRβ autophosphorylation [19][20][21][22]. Although the mechanisms underlying the inhibitory effect of these polyphenols remain to be established, previous studies suggested that some of these molecules may inhibit the activation of receptor tyrosine kinase by competing with adenosine triphosphate for binding to the kinase domain of the receptor, resulting in impaired activation of key signaling intermediates [23,24].…”
Section: Discussionmentioning
confidence: 99%
“…Baicalin belongs to a class of polyphenols. Previous studies have shown that polyphenols inhibit PDGFRβ autophosphorylation [19][20][21][22]. Although the mechanisms underlying the inhibitory effect of these polyphenols remain to be established, previous studies suggested that some of these molecules may inhibit the activation of receptor tyrosine kinase by competing with adenosine triphosphate for binding to the kinase domain of the receptor, resulting in impaired activation of key signaling intermediates [23,24].…”
Section: Discussionmentioning
confidence: 99%
“…These preliminary RCT findings are supported by animal and in vitro data. Anthocyanins inhibit atherosclerosis development, alter cell signalling pathways involved in vascular inflammation, and reduce infarct size following coronary occlusion and perfusion (Lamy et al 2008;Toufektsian et al 2008). Mechanistic studies also suggest an impact on whole body insulin action (DeFuria et al 2009;Inaguma, Han, and Isoda 2011;Stull et al 2010).…”
Section: Randomised Controlled Trials (Rcts)mentioning
confidence: 99%
“…Confluent pulmonary aortic smooth muscle cells were incubated for 18 h in 0.5% fetal bovine serum containing either vehicle (DMSO) or flavonoids and stimulated with 50 ng/mL PDGF-BB for 5 min. Cells were washed and solubilized on ice in lysis buffer [150 mmol/L NaCl, 10 mmol/L Tris-HCl (pH 7.4), 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L NaF, 1 mmol/L Na 3 VO 4 , 0.5% (v/v) NP40, and 1% (v/v) Triton X-100], and the resulting lysates were processed for immunoprecipitation studies as previously described (26). Briefly, lysates (200 μg protein) from each sample were incubated in lysis buffer overnight at 4°C in the presence of 1 μg/mL of anti-PDGFR-β antibodies, and immune complexes were collected by incubating the mixture with 25 μL (50% suspension) of Protein A-Sepharose beads for 2 h. Bound proteins were solubilized in 2-fold concentrated Laemmli sample buffer [125 mmol/L Tris-HCl (pH 6.8), 20% glycerol, 4% SDS, 10% β-mercaptoethanol, and 0.00125% bromophenol blue], boiled for 4 min, and resolved by SDS-PAGE (7.5% gel).…”
Section: Inhibition Of Pdgfr-β Phosphorylation and Downstream Signalimentioning
confidence: 99%
“…The Matrigel plug assay was done essentially as described previously (26,27). Briefly, female nude mice (Crl:CD-1-Foxn1 nu ; 20-25 g, 6 wk of age; Charles River Laboratories) were treated by injection s. c. into the ventral midline region of the right flank with 0.5 mL of phenol red-free Matrigel (BD Bioscience) containing apigenin (25 μmol/L) or luteolin (50 μmol/L), FGF-2 (250 ng/mL), VEGF (200 ng/mL), and heparin (0.0025 units/mL).…”
Section: In Vivo Matrigel Plug Assaymentioning
confidence: 99%